Skip to main content
Premium Trial:

Request an Annual Quote

AIM s della Cioppa Dies; Glenn Nedwin Named CSO at Dyadic; James Glover to Leave Beckman; 454 Gets New Business Development Veep; Stephen Lammert to Develop Mass-Spec Line at Stillwater; and Others

Guy della Cioppa, the head of business development at Advanced Ideas in Medicine, died on March 3 after his vehicle veered off a road near Davis, Calif., and hit a tree. He was 56.


According to a local newspaper, della Cioppa was alone, driving a rented Ford Taurus westbound on County Road 31 when the vehicle drifted from the road. He died at from a blunt chest injury.


Della Cioppa served as vice president of business development at Predictive Diagnostics until June 2005, when he left the company to form AIM, a new company that focuses on proteomic-based diagnostics for the early detection of cancer.

Dyadic International appointed Glenn Nedwin chief scientific officer, executive vice president and president of biosciences business, effective today.


Nedwin is the co-founder and president of Novozymes. Prior to that he was vice president of corporate development at Califronia-based Xoma and Ideon. He is the co-founder of Molecular Therapeutic.

James Glover will retire from Beckman Coulter on June 30, the company said today.


In an SEC filing the company said that Glover, chief financial officer, will retain his current pay and benefits for 18 months after his retirement date, that he will receive a pro-rated bonus for 2006, and his stock options will vest early, on his retirement date.

Wyeth Wasserman has been named a scientific advisor of Upstream Biosciences, the company said yesterday.


Wasserman is a professor at the University of British Columbia and a senior scientist at the Centre for Molecular Medicine and Therapeutics. He has held positions at GlaxoSmithKline and Pharmacia, which has since been acquired by Pfizer.

John Alsobrook has joined Exagen as director, genomic marker discovery, the company said yesterday.


Alsobrook comes to Exagen after four years as an independent consultant. Previously he was at CuraGen.

Teranode appointed three new managers Monday. They are Murthy Srinivas, president of product and platform development; John Ohrn, vice president sales; and Yoram Lapid, vice president sales and support.


Srinivas was the founder and vice president of engineering at Consera Software, which was acquired by Hewlett Packard. Prior to that he had positions at Banyan Systems, Atria and Microsoft.


Ohrn was director of sales and support at Accelrys before joining Teranode.


Lapid was a director of design and consulting services at Cadence Design Systems. He was also vice president of engineering at Solidium Systems and Philsar Semiconductors.

Dexter Pratt was promoted to vice president, knowledge modeling at Genstruct, the company said Monday.


Pratt began consulting for Genstruct in 2002 and became director of biological systems modeling in 2003. He led the company's internal prostate cancer program and diabetes program with Pfizer. Prior to Genstruct he was at Internet Media Group, Pearson Education and on research staff at the MIT artificial intelligence lab.

Stephen Lammert has joined Stillwater to lead development of a new line of mass spectrometers, the company said last week.


Lammert has consulted for Palmar Technologies/Brigham Young University and Research Triangle Institute. He has also held R&D roles at Oak Ridge. He began mass spectrometry work at Perkin-Elmer and Thermo Finnigan.

Shaun Lonergin, vice president of business development at 454 Life Sciences, has left the company.


The company has named Katherine Webster vice president of sales.

Rich Ellson, chief technical officer of Labcyte, has been awarded the 2006 PolyPops Foundation Award by the Society for Biomolecular Sciences, the company announced today.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.